India · Delayed Price · Currency is INR Genpharmasec Statistics
Total Valuation
Genpharmasec has a market cap or net worth of INR 548.18 million. The enterprise value is 790.71 million.
| Market Cap | 548.18M |
| Enterprise Value | 790.71M |
Important Dates
The next estimated earnings date is Friday, November 6, 2026.
| Earnings Date | Nov 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Genpharmasec has 553.72 million shares outstanding.
| Current Share Class | 553.72M |
| Shares Outstanding | 553.72M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 39.76% |
| Owned by Institutions (%) | n/a |
| Float | 319.18M |
Valuation Ratios
The trailing PE ratio is 84.61.
| PE Ratio | 84.61 |
| Forward PE | n/a |
| PS Ratio | 0.31 |
| PB Ratio | 0.84 |
| P/TBV Ratio | 1.14 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 122.04 |
| EV / Sales | 0.45 |
| EV / EBITDA | 61.39 |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.71, with a Debt / Equity ratio of 0.53.
| Current Ratio | 1.71 |
| Quick Ratio | 0.86 |
| Debt / Equity | 0.53 |
| Debt / EBITDA | 27.13 |
| Debt / FCF | n/a |
| Interest Coverage | -0.88 |
Financial Efficiency
Return on equity (ROE) is 0.86% and return on invested capital (ROIC) is -1.48%.
| Return on Equity (ROE) | 0.86% |
| Return on Assets (ROA) | -0.46% |
| Return on Invested Capital (ROIC) | -1.48% |
| Return on Capital Employed (ROCE) | -0.88% |
| Weighted Average Cost of Capital (WACC) | 4.88% |
| Revenue Per Employee | 136.62M |
| Profits Per Employee | 498,385 |
| Employee Count | 13 |
| Asset Turnover | 1.28 |
| Inventory Turnover | 12.14 |
Taxes
In the past 12 months, Genpharmasec has paid 8.11 million in taxes.
| Income Tax | 8.11M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -43.02% in the last 52 weeks. The beta is 0.28, so Genpharmasec's price volatility has been lower than the market average.
| Beta (5Y) | 0.28 |
| 52-Week Price Change | -43.02% |
| 50-Day Moving Average | 1.08 |
| 200-Day Moving Average | 1.13 |
| Relative Strength Index (RSI) | 40.37 |
| Average Volume (20 Days) | 388,354 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Genpharmasec had revenue of INR 1.78 billion and earned 6.48 million in profits.
| Revenue | 1.78B |
| Gross Profit | 133.89M |
| Operating Income | -13.36M |
| Pretax Income | -177,000 |
| Net Income | 6.48M |
| EBITDA | 12.88M |
| EBIT | -13.36M |
| Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has 100.74 million in cash and 349.47 million in debt, with a net cash position of -248.73 million or -0.45 per share.
| Cash & Cash Equivalents | 100.74M |
| Total Debt | 349.47M |
| Net Cash | -248.73M |
| Net Cash Per Share | -0.45 |
| Equity (Book Value) | 656.45M |
| Book Value Per Share | 1.08 |
| Working Capital | 334.96M |
Cash Flow
In the last 12 months, operating cash flow was -175.52 million and capital expenditures -5.21 million, giving a free cash flow of -180.73 million.
| Operating Cash Flow | -175.52M |
| Capital Expenditures | -5.21M |
| Depreciation & Amortization | 26.24M |
| Net Borrowing | 49.69M |
| Free Cash Flow | -180.73M |
| FCF Per Share | -0.33 |
Margins
Gross margin is 7.54%, with operating and profit margins of -0.75% and 0.36%.
| Gross Margin | 7.54% |
| Operating Margin | -0.75% |
| Pretax Margin | -0.01% |
| Profit Margin | 0.36% |
| EBITDA Margin | 0.73% |
| EBIT Margin | -0.75% |
| FCF Margin | n/a |
Dividends & Yields
Genpharmasec does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 1.18% |
| FCF Yield | -32.97% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on April 11, 2019. It was a forward split with a ratio of 10.
| Last Split Date | Apr 11, 2019 |
| Split Type | Forward |
| Split Ratio | 10 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |